
Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediatesBusiness Overview: CEL is an ISO 9001:2015, ISO 14001:2015 and ISO 50001:2018 certified company. It specializes in High Pressure Oxidation, Nitration, Chlorosulfonation and Amidation Chemistry - manufacturing intermediates for bulk drugs(API), dyes & pigment, electro-plating, pharmaceuticals, dyes and pigments industries
Chemcrux Enterprises announced its 30th Annual General Meeting (AGM) will be held virtually. The company has electronically sent the Annual Report for FY 2025-26 and the AGM Notice to shareholders with registered email IDs. For those whose emails are not registered, the company has provided web-links to access these crucial...
The company has proposed a dividend of Re. 1/- per equity share for FY 2025-26, pending shareholder approval at the upcoming Annual General Meeting. The record date for dividend eligibility is September 10. The company will deduct tax at source on this dividend, which is taxable in shareholders' hands. Resident...
CHEMCRUX Enterprises announced that Mr. Bhanubhai Patel and Mr. Shailesh Patel have ceased to be Independent Directors of the company. Their departure is due to the completion of their second five-year term, marking the end of their maximum permitted tenure. The company clarified there are no other reasons for their...
Here are the summaries based on your preferences: **CHEMCRUX ENTERPRISES LIMITED:** CHEMCRUX ENTERPRISES LIMITED will hold its 30th Annual General Meeting on Thursday, September 17, 2026, at 02:00 PM (IST) via video conference. The company has informed shareholders about the AGM and the annual report for FY 2025-26. Share transfer...
CHEMCRUX Enterprises Limited has announced its 30th Annual General Meeting (AGM) will be held via video conference on 17th September. To prepare for the AGM and determine shareholder eligibility for voting and potential dividends, the company has set a book closure period from 11th September to 17th September. The record...